2.3.1.7: carnitine O-acetyltransferase
This is an abbreviated version!
For detailed information about carnitine O-acetyltransferase, go to the full flat file.
Word Map on EC 2.3.1.7
-
2.3.1.7
-
peroxisomal
-
palmitoyltransferase
-
beta-oxidation
-
acyl-coas
-
l-carnitine
-
acyltransferases
-
clofibrate
-
palmitoyl-coa
-
acylcarnitine
-
proliferators
-
hypolipidemic
-
octanoyltransferase
-
cyanide-insensitive
-
propionylation
-
cardos
-
acetyl-l-carnitine
-
carbazole
-
carnitine-dependent
-
cronbach
-
alloy
-
1,9a-dioxygenase
-
coash
-
peroxisome-associated
-
palmitoylcarnitine
-
nafenopin
-
bezafibrate
-
ciprofibrate
-
food industry
-
analysis
-
medicine
- 2.3.1.7
- peroxisomal
- palmitoyltransferase
-
beta-oxidation
- acyl-coas
- l-carnitine
- acyltransferases
- clofibrate
- palmitoyl-coa
- acylcarnitine
- proliferators
-
hypolipidemic
-
octanoyltransferase
-
cyanide-insensitive
-
propionylation
- cardos
- acetyl-l-carnitine
- carbazole
-
carnitine-dependent
-
cronbach
-
alloy
-
1,9a-dioxygenase
- coash
-
peroxisome-associated
- palmitoylcarnitine
-
nafenopin
- bezafibrate
- ciprofibrate
- food industry
- analysis
- medicine
Reaction
Synonyms
acetyl-CoA-carnitine O-acetyltransferase, acetylcarnitine transferase, acuJ, CarAc, CARAT, carnitine acetyl coenzyme A transferase, carnitine acetyl transferase, carnitine acetylase, carnitine acetyltransferase, carnitine acetyltransferase CAT2, carnitine acetyltransferase Cat2p, carnitine acetyltransferase Yat1p, carnitine acetyltransferase Yat2p, carnitine-acetyl-CoA transferase, CAT, CAT2, CATC, CRAT, CT-CAT, CTN1, CTN2, CTN3, H-CAT, P-CAT, S-CAT1, S-CAT2, Yat1
ECTree
Advanced search results
Application
Application on EC 2.3.1.7 - carnitine O-acetyltransferase
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
analysis
food industry
modulating aroma compounds during wine fermentation by manipulating carnitine acetyltransferases in Saccharomyces cerevisiae
medicine
-
specific activity is higher than in commercial preparations from other sources, enzyme prepared from yeast may be used for determination of carnitine in biological materials, this preparation is free of acetyl-CoA-deacetylase activity
analysis
-
in medicine and biochemical practice, the enzyme isolated from breast muscle is used analytically
analysis
-
enzyme in pure form facilitates assay of carnitine and its acyl derivatives in tissues
analysis
-
determination of free and total carnitine in plasma by an enzymatic reaction and spectrophotometric quantitation spectrophotometric determination of carnitine. the detection limit is 0.0017 mM/l in plasma
analysis
-
paper chromatography-based assay for the detection of acetylcholine and L-acetylcarnitine. The assay can be used to measure both choline acetyltransferase and carnitine acetyltransferase activity in the same samples
analysis
-
paper chromatography-based assay for the detection of acetylcholine and L-acetylcarnitine. The assay can be used to measure both choline acetyltransferase and carnitine acetyltransferase activity in the same samples
medicine
-
dysregulation of the enzyme can lead to serious diseases in humans, inherited deficiency in CRAT activity can lead to neurological and heart problems, patients suffering from Alzheimer 's disease also have reduced CRAT activity, promising target for therapeutic development against several human diseases like diabetes
medicine
-
pharmacological applications, patients suffering from CARAT deficiency, serious neurological, motor, repiratory and heart problems observed
medicine
-
CAT is clinically used in evaluating L-CA and its esters in body fluids and tissues
medicine
CRAT function is not the major contributor to primary insulin resistance in cultured myotubes obtained from obese type 2 diabetes mellitus patients. mRNA levels and protein abundance of CRAT are similar between from obese persons with or without type 2 diabetes mellitus and lean controls. Of 14 different acylcarnitine species measured, the levels of palmitoylcarnitine and octadecanoylcarnitine are slightly reduced in myotubes derived from type 2 diabetes mellitus patients compared to glucose-tolerant obese and lean controls